Awards & Advancement

Novogen appoints Iain Ross acting CEO, reappoints him to board

Monday, July 27, 2015 12:29 PM

Novogen, a U.S.-Australian drug development company, has reappointed Iain Ross to the board. Ross, a former director of Novogen, also will become acting chief executive until a permanent appointment is made.

More... »


DrugDev president, CEO Ibraheem Mahmood wins PM360 ELITE award

Monday, July 27, 2015 08:00 AM

Ibraheem (Ibs) Mahmood, DrugDev president and CEO, has been voted among only six executives worldwide as a winner in the “Disrupter” category in its inaugural ELITE award program by PM360, a health-marketing industry trade magazine.

More... »


Cloud Pharmaceuticals expands advisory board

Thursday, July 23, 2015 12:17 PM

Cloud Pharmaceuticals, a therapeutics company focused on cloud-based drug design and development, has added members to its advisory board. The board is comprised of four leaders from industry and academia with experience in complex molecular and macromolecular systems, biophysics, translational research and drug discovery and development. The advisors collaborate with Cloud Pharmaceuticals’ board of directors to provide insight on needs and opportunities within the pharmaceutical industry.

More... »

DrugDev founder Melissa Easy is 2015 Partnerships in Clinical Trials Woman of the Year

Thursday, July 23, 2015 11:15 AM

DrugDev has announced Melissa (Liss) Easy, company founder and current president of DrugDev SiteStart, is the 2015 Partnerships in Clinical Trials Woman of the Year.

More... »

PPD achieves CEO Cancer Gold Standard reaccreditation

Thursday, July 23, 2015 11:11 AM

Pharmaceutical Product Development (PPD) has achieved CEO Cancer Gold Standard reaccreditation from the nonprofit CEO Roundtable on Cancer for maintaining a strong commitment to the health of company employees.

More... »

Dr. Anahita Keyhani joins Algorithme as director, method development

Friday, July 17, 2015 10:06 AM

Algorithme Pharma, a full service provider focused on early stage clinical research with over twenty years of experience, has hired Dr. Anahita Keyhani. Keyhani brings almost two decades of experience to her new role as director, method development, previously senior research scientist at Charles River Laboratories.

More... »

Certara appoints Tristen Herrstrom as senior vice president of human resources

Thursday, July 16, 2015 08:00 AM

Certara, a global biosimulation technology-enabled drug development company, has appointed Tristen Herrstrom to the newly-created position of senior vice president of human resources.

More... »

Douglas Williams to leave Biogen for biotechnology start-up

Wednesday, July 15, 2015 01:21 PM

Douglas Williams, Ph.D., will leave Biogen at the end of July to become CEO of as-yet unnamed start-up biotechnology company. Williams will be the first member of a new organization with potential in cancer diagnostics and therapy.

More... »

Zogenix expands senior leadership team

Friday, July 10, 2015 09:59 AM

Zogenix, a pharmaceutical company developing and commercializing products for the treatment of central nervous system (CNS) disorders, has appointed Gail M. Farfel, Ph.D., executive vice president and chief development officer, and Thierry Darcis, M.D., M.B.A., executive vice president and general manager, Europe.

More... »

Almac Group appoints two new vice presidents

Wednesday, July 8, 2015 11:43 AM

Almac Group, a global contract development and manufacturing organization, has appointed two new vice presidents at its Craigavon and Souderton headquarter facilities.

More... »

CWWeekly

July 27

AB Science warned about putting study volunteers in danger

FDA, Google unite to detect search-data adverse events

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

July

Integrated research partnerships build momentum
Research function provides infrastructure, leverages large pool of health systems' patients and data

'Right to Try' laws challenge clinical trial process
20 states pass, 20 more pending allowing access to study drugs without FDA and IRB approval

Already a subscriber?
Log in to your digital subscription.

Purchase the July issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

June

TransCelerate Biopharma turns three
High-profile consortium has made inroads fixing wasteful practices, but it still has more work ahead

Pharma industry improves its tarnished reputation
Delivering innovation, social responsibility will help rebuild trust

Already a subscriber?
Log in to your digital subscription.

Purchase the June issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs